February, 2003
© 2000, 2001
Scott S. Emerson, M.D., Ph.D.
And there is no
advantage in continuing
Even if
confident of ultimate decision about primary endpoint, may want to
continue trial to gain more information on
·Safety
·Longer term
follow-up
·Gather
additional data on secondary outcomes